Akbar Ali

Dr. Akbar Ali

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Transgenic Research
Verified
Journal Article
Closed access
PDF file
NKNasar Khan
Nasar Khan
ZLZhouyan Li
Zhouyan Li
AAAkbar Ali
Akbar Ali
BQBiaohu Quan
Biaohu Quan
JKJindan Kang
Jindan Kang
Muhammad ShafiqMuhammad Shafiq
Muhammad Shafiq

26 April 2024
Verified
Book Chapter
Closed access
ARAamir Raza
Aamir Raza
SMSheraz Maqbool
Sheraz Maqbool
MSMuhammad Safdar
Muhammad Safdar
HAHasnain Ali
Hasnain Ali
IUIkram Ullah
Ikram Ullah
AMAbdul Malik
Abdul Malik
Remote sensing is a crucial technique in environmental and spatial investigations, and Python is a popular programming language for analyzing this data. This chapter provides a comprehensive guide to using Python for remote sensing data analysis, covering various data types, attributes, and practical implementations. It introduces Python and its data processing libraries, discusses preprocessing operations like data conversion and import, geometric rectification, and radiometric correction, and covers image enhancement techniques like edge detection, contrast enhancement, and filtering. It also covers image analysis techniques like band mathematics, indices, classification, and segmentation. The chapter also covers exporting data and generating visualization maps and charts. Python's application in remote sensing data analysis is illustrated through case studies. Request access from your librarian to read this chapter's full text.

28 September 2023 in medRxiv
Verified
Preprint
Open access
PDF file
AAAkbar Ali
Akbar Ali
LZLi Zhang
Li Zhang
HLHongsheng Liu
Hongsheng Liu
1 Esophageal carcinoma (EC) ranks among the top six most prevalent malignancies worldwide with a recent surge in incidence. An innovative integrated omics technique is presented for discerning the two primary types of esophageal carcinoma (EC) AND Squamous cell carcinoma and adenocarcinoma. Utilizing The Cancer Genome Atlas (TCGA) data via Bioconductor, the research integrated DNA methylation and RNA expression analyses for esophageal cancer (ESCA). Key findings revealed DNA methylation’s pivotal role in ESCA progression and its potential as an early detection biomarker. Significant disparities in methylation patterns offered insights into the disease’s pathogenesis. A comparison with the TCGA Pan-Cancer dataset using Bioconductor tools enriched the understanding of ESCA genomics. Specifically, 131,220 hypomethylated probes were detected in tumors compared to 6,248 in healthy tissues. Additionally, 42,060 probe-gene pairs linked methylation variations to expression alterations, with 768 hypomethylated motifs identified. Thirteen of these motifs emerged as potential diagnostic markers. Transcription factor analyses spotlighted crucial regulators, including NFL3, ATF4, JUN, and CEBPG, revealing intricate regulatory networks in ESCA. Survival statistics further correlated clinical factors with patient longevity. This research recommends an innovative approach to identifying oesophageal abnormalities through DNA methylation and gene expression mechanisms. Research suggests DNA methylation may serve as an early detection biomarker, aiding in identifying esophagus cancer prior to more advanced stages.

7 April 2026 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
KMKarar Nadhum Jawad Musafer
Karar Nadhum Jawad Musafer
AAAkbar Ali
Akbar Ali
TDTengku Ahmad Damitri Al-Astani Tengku Din
Tengku Ahmad Damitri Al-Astani Tengku Din
HAHeba Mohammed Arafat
Heba Mohammed Arafat
MJMuhammad Irfan Abdul Jalal
Muhammad Irfan Abdul Jalal
AAAli Obaid Alhujiri
Ali Obaid Alhujiri
Type 2 diabetes mellitus (T2DM) is a major cause of morbidity in the Middle East; however, Arab populations remain underrepresented in genomic studies. We synthesized evidence on single-nucleotide polymorphisms (SNPs) associated with T2DM risk in Egyptian and Levant (Jordan, Lebanon, Palestine, and Syria) cohorts to identify shared and population-specific loci. We conducted a PRISMA-aligned systematic review and meta-analysis (PROSPERO CRD420251162068) of case–control genetic studies published until July 2025. Eligible studies enrolled ≥ 60 participants, reported odds ratios (ORs) with 95% confidence intervals (CIs), and satisfied the Hardy–Weinberg equilibrium in controls. Pooled effects used fixed- and random-effects models according to heterogeneity (Cochran’s Q, I², and τ²). Publication bias was assessed using Egger’s and Begg’s tests and funnel plot symmetries. Sensitivity analyses included leave-one-out procedures and meta-regression using study-level moderators (case/control counts). Exploratory clustering and random forest models were used to examine gene/SNP features related to effect size. In Egyptians (45 SNPs), between-study heterogeneity was negligible (Q = 35.32, df = 43, p = 0.79; I² = 0%; τ² = 0). Strong risk associations were observed for IGFB rs2854843 (OR = 13.30, p = 0.001), MTHFR rs1801133 (OR = 4.60, p = 0.001), GCKR rs780094 (OR = 3.99, p = 0.001), and TCF7L2 rs12255372 (OR = 2.06, p = 0.0001); additional signals were observed for ADIPOQ and KCNJ11. Egger’s test suggested minor small-study effects (p = 0.0184), whereas Begg’s test did not (p = 0.721). Meta-regression indicated that larger case counts and smaller control counts were associated with inflated ORs (R² ≈ 0.15). In the Levant cohort (29 SNPs), heterogeneity was high (Q = 302.32, df = 28, p < 0.0001; I² = 90.7%). Notable loci included NAT2 rs1799931 (OR = 13.72, p = 0.043) and SH2B1 rs565131715 (OR = 7.55), with lower magnitude associations for ADIPOQ and KCNQ1. No significant publication bias was detected. Egyptian findings revealed consistent large-effect SNP associations with T2DM, whereas Levant populations showed variable context-dependent effects. Shared markers (TCF7L2, ADIPOQ, and KCNJ11) and population-specific candidates (IGFB, NAT2, and SH2B1) may inform targeted screening and risk stratification. Harmonized, adequately powered multicenter studies are needed to validate these findings and accelerate precision medicine in underrepresented Arab populations. The online version contains supplementary material available at 10.1186/s13098-026-02103-5.

3 April 2026 in Epigenomics
Verified
Journal Article
Closed access
AAAkbar Ali
Akbar Ali
TDTengku Ahmad Damitri Al-Astani Tengku Din
Tengku Ahmad Damitri Al-Astani Tengku Din
MJMuhammad Irfan Abdul Jalal
Muhammad Irfan Abdul Jalal
WAWan Nor Arifin
Wan Nor Arifin
Mai Abdel Haleem A. AbuSalahMai Abdel Haleem A. AbuSalah
Mai Abdel Haleem A. AbuSalah
Naveed AhmedNaveed Ahmed
Naveed Ahmed
Esophageal carcinoma (ESCA), comprising esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), has a poor prognosis due to late diagnosis and incomplete molecular characterization. We sought to define the ESCA epigenomic landscape by integrating methylome and transcriptome data across both subtypes. TCGA-ESCA HumanMethylation450K and RNA-seq profiles (182 tumors: 95 ESCC and 87 EAC; 64 normal tissues) were analyzed using ELMER and Bioconductor workflows. Differentially methylated probes were annotated by genomic category, probe-gene coupling was tested by Spearman correlation, and a LASSO-penalized 12-CpG classifier was trained and externally validated in an independent GEO cohort (GSE68303; n = 43). ESCA showed pervasive enhancer hypomethylation, with 72.5% of the hypomethylated probes mapping to the distal enhancers. Methylation-expression coupling identified LINC02547 and PYGL as candidate effector genes, and enriched transcription factor motifs included AP-1 and NFIL3. The classifier achieved a cross-validated AUC of 0.996, approximately 0.99, sensitivity at 95% specificity, and reproducible performance across ESCC and EAC subtypes. Advanced disease stage was the dominant prognostic factor in multivariable survival models. Enhancer hypomethylation is a hallmark of ESCA, nominating LINC02547 and PYGL as biomarker candidates with diagnostic/prognostic promise. Limitations include retrospective design and need for experimental validation.

15 July 2026 in Journal of Proteome Research
Verified
Journal Article
Open access
AAAkbar Ali
Akbar Ali
TDTengku Ahmad Damitri Al-Astani Tengku Din
Tengku Ahmad Damitri Al-Astani Tengku Din
MMMaulidiani Maulidiani
Maulidiani Maulidiani
HAHeba Mohammed Arafat
Heba Mohammed Arafat
WRWan Faiziah Wan Abdul Rahman
Wan Faiziah Wan Abdul Rahman
WAWan Norlina Wan Azman
Wan Norlina Wan Azman
Breast cancer (BC) is the most common malignancy among women, and late-stage presentation remains common in Asia, highlighting the need for affordable and minimally invasive adjuncts to imaging. This study evaluated whether fasting serum 1H NMR metabolomics could distinguish Malaysian women with newly diagnosed treatment-naïve BC from healthy controls and identify perturbed metabolic pathways. After spectral quality control exclusion, 101 participants were analyzed (BC, n = 44; control, n = 57). PCA and oOPLS-DA showed group separation, and 14 metabolites were deferred significantly after false discovery rate correction. Endogenous metabolites evaluated in BC included 3-hydroxybutyrate, citrate, glutamine, malonate, phenylalanine, dimethyl sulfone, myo-inositol, and L-carnitine, and the levels of formate, tyrosine, histamine, and p-hydroxyphenylacetate were reduced. Acetylsalicylate and salicylate were classified as exogenous aspirin-related markers and were excluded from the endogenous biomarker panel. Pathway analysis indicated disruptions in the tricarboxylic acid (TCA) cycle, glyoxylate/dicarboxylate metabolism, butanoate metabolism, and amino acid pathways. Metabolite-based classifiers achieved 0.901 accuracy on an internal held-out test partition (AUC 0.942) and 0.902 ± 0.061 accuracy in repeated stratified 5-fold cross-validation. These internally validated findings define a BC-associated serum metabolomic signature in a Southeast Asian cohort and warrant independent external validation.